AI news impact · China A-shares
CanSino Biologics, Inc. Class A (688185) news impact
On 2026-09-30 Wave Radar's AI rated the news on CanSino Biologics, Inc. Class A as neutral (impact score 0%).
News only involves the disclosure of routine margin trading balance changes and Q2 institutional holdings for the company.
- Direction
- Neutral
- Impact score
- 0%
- Confidence
- 90%
- Headlines read
- 4
- Date
- 2026-09-30
AI assessment
CanSino's recent news only involved capital flow data and institutional holding statistics, lacking substantive events affecting company fundamentals or short-term operations.
Sector impact
No significant sector impact.
Headlines the AI read
- 科创板股融资融券余额每日变动(9月28日) AkShare/证券时报网 · 2026-09-29
- 287只科创板股融资余额环比增加 AkShare/证券时报网 · 2026-09-23
- 75只科创板股获融资净买入超1000万元 AkShare/证券时报网 · 2026-09-23
- 机构风向标 | 康希诺6881852026年二季度已披露持仓机构仅2家 AkShare/界面新闻 · 2026-08-28
Rating history
One rating per trading day the stock was covered.
More on CanSino Biologics, Inc. Class A
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.